Key Financial Data Of Reporting Company

Pharmarise Holdings Corporation - Filing #7289113

Concept As at
2024-11-30
2024-06-01 to
2024-11-30
2023-06-01 to
2024-05-31
As at
2024-05-31
As at
2023-11-30
2023-06-01 to
2023-11-30
Key financial data of reporting company
Business results of reporting company
Net sales
30,544,000,000 JPY
54,466,000,000 JPY
26,948,000,000 JPY
Ordinary profit (loss)
29,000,000 JPY
833,000,000 JPY
701,000,000 JPY
Net assets
7,163,000,000 JPY
7,442,000,000 JPY
8,391,000,000 JPY
Total assets
30,457,000,000 JPY
29,486,000,000 JPY
22,966,000,000 JPY
Basic earnings (loss) per share
-10.09
-33.41
28.29
Diluted earnings per share
26.99
Equity-to-asset ratio
0.226 xbrli:pure
0.243 xbrli:pure
0.353 xbrli:pure
Net cash provided by (used in) operating activities
-200,000,000 JPY
2,714,000,000 JPY
1,860,000,000 JPY
Net cash provided by (used in) investing activities
-537,000,000 JPY
-3,120,000,000 JPY
-543,000,000 JPY
Net cash provided by (used in) financing activities
1,138,000,000 JPY
2,771,000,000 JPY
-1,128,000,000 JPY
Cash and cash equivalents
7,504,000,000 JPY
7,100,000,000 JPY
4,923,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.